About Amulet

Shaping the Future of Healthcare

We invest exclusively in healthcare, partnering with outstanding management
teams to create lasting impact. We specialize in situations where deep sector
expertise, structured entry, and hands-on value creation can build durable
leaders. Our approach is shaped by four guiding principles:

01

Focus

Depth over breadth; specialization that endures across cycles.

02

Vision

Act where others see friction; unlock hidden opportunity.

03

Stewardship

Alignment, governance, and hands-on operator support drive results.

04

Legacy

Programmatic M&A and durable unit economics ensure long-term value.

A Decade of
Impact

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
  • Amulet founded on a thesis of deep sector expertise and long-term partnership
  • First investment in Synteract
  • Fund I closes at $288M (Target $200M)
  • OPEN Health and Choice Healthcare Services investments;
  • Nick Amigone promoted to Partner
  • Acquisition of U.S. Digestive Health
  • Acquisition of US Fertility (“USF”) & SSI Strategy;
  • Exit of Synteract
  • Fund II closes at $650M (Target $500M)
  • Acquisition of HealthCentral (fka Remedy Health Media);
  • USF / Stork SPV closes at $325M;
  • Walnut Creek office opened
  • OPEN Health exit;
  • Lighthouse Behavioral Health Solutions and United Vein & Vascular Centers investments
  • Formation of the Portfolio Resource Group;
  • Unlock Health acquisition;
  • Alliance Clinical Network and Assembled Intelligence (fka minds + assembly) investments;
  • Merger of USF and Ovation Fertility completed
  • Carl Zimmerman promoted to Partner
  • Fund III closes at $1.2B (Target $1B)
  • Acquisitions of GIVF Institute, Theoria Medical;
  • Assembled Intelligence merges with BOLDSCIENCE;
  • Avi Uttamchandani promoted to Partner;
  • Hired Michael Keaveney, Partner and Head of Investor Relations
  • Exit of U.S. Digestive Health
  • Exit of SSI Strategy
  • Amulet forms strategic partnership with L Catterton and Fund II asset, US Fertility
2015 milestone: Amulet Capital founded, close-up of laboratory microscope equipment
2016 milestone: first major investment activity, person signing business and legal documents
2017 milestone: early platform development, precision instruments working on cell sample in petri dish
2018 milestone: Fund I momentum and expansion, gloved hands holding blood sample test tubes
2019 milestone: healthcare platform investments, stethoscope resting on patient medical records
2020 milestone: US Fertility and SSI Strategy acquisition, lab technician using pipette under microscope
2021 milestone: platform growth and operations, nurse documenting patient information on clipboard
2022 milestone: Fund II progress and investments, scientists working in a medical laboratory
2023 milestone: portfolio expansion and healthcare growth, lab test tubes in automated analyzer
2024 timeline: Fund III closes and portfolio expands, business team discussing strategy
2025 timeline: Amulet forms strategic partnership with L Catterton and US Fertility, abstract healthcare investment visual
Our Responsibility